atc_code
stringlengths 1
7
| atc_name
stringlengths 3
95
| ddd
float64 0.1
800
⌀ | uom
stringclasses 10
values | adm_r
stringclasses 18
values | note
stringclasses 96
values |
|---|---|---|---|---|---|
J07AH08 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated | null | null | null | null |
D04AA | Antihistamines for topical use | null | null | null | null |
M01AE03 | ketoprofen | 0.15 | g | O | null |
C01AA06 | lanatoside C | 1 | mg | O | null |
C10BX08 | atorvastatin and acetylsalicylic acid | null | null | null | null |
A10BD22 | metformin and evogliptin | null | null | null | null |
S01EB02 | carbachol | 0.4 | ml | null | null |
A10AE01 | insulin (human) | 40 | U | P | null |
C08D | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS | null | null | null | null |
C01DX04 | benziodarone | 0.25 | g | O | null |
H01BA02 | desmopressin | 0.4 | mg | O | null |
V08DA03 | perflenapent | null | null | null | null |
D01BA01 | griseofulvin | 0.5 | g | O | null |
G04CA02 | tamsulosin | 0.4 | mg | O | null |
R03CC13 | clenbuterol | 40 | mcg | O | null |
J02AA02 | hachimycin | null | null | null | null |
C05BB | Sclerosing agents for local injection | null | null | null | null |
A12AA04 | calcium carbonate | 3 | g | O | null |
N02AJ03 | dihydrocodeine and other non-opioid analgesics | null | null | null | null |
G03DB07 | promegestone | null | null | null | null |
D05B | ANTIPSORIATICS FOR SYSTEMIC USE | null | null | null | null |
A03AD02 | drotaverine | 0.1 | g | P | null |
B05XA15 | potassium lactate | null | null | null | null |
G01BE | Sulfonamides and corticosteroids | null | null | null | null |
M05BC02 | eptotermin alfa | null | null | null | null |
A14AA01 | androstanolone | null | null | null | null |
V03AX | Other therapeutic products | null | null | null | null |
D08AB | Aluminium agents | null | null | null | null |
S01CA06 | fludrocortisone and antiinfectives | null | null | null | null |
V03AE02 | sevelamer | 6.4 | g | O | null |
D01AC20 | imidazoles/triazoles in combination with corticosteroids | null | null | null | null |
N06BA14 | solriamfetol | null | null | null | null |
A10BH51 | sitagliptin and simvastatin | null | null | null | null |
R06AX21 | tritoqualine | null | null | null | null |
N06CA | Antidepressants in combination with psycholeptics | null | null | null | null |
R03AK05 | reproterol and sodium cromoglicate | null | null | null | null |
N02BG02 | rimazolium | 0.9 | g | O | null |
A02BD08 | bismuth subcitrate, tetracycline and metronidazole | null | null | null | null |
C07CA | Beta blocking agents, non-selective, and other diuretics | null | null | null | null |
R01AD12 | fluticasone furoate | 0.11 | mg | N | null |
P02BA01 | praziquantel | 3 | g | O | null |
D03AX14 | Centella asiatica herba | null | null | null | null |
V09IX05 | fluorodopa (18F) | null | null | null | null |
L04AA37 | baricitinib | 4 | mg | O | null |
A02BX05 | bismuth subcitrate | 0.48 | g | O | null |
R06AX13 | loratadine | 10 | mg | O | null |
J01GB08 | sisomicin | 0.24 | g | P | null |
H03CA | Iodine therapy | 0.33 | g | P | null |
A02AB10 | combinations | null | null | null | null |
M04A | ANTIGOUT PREPARATIONS | null | null | null | null |
R06AA02 | diphenhydramine | 0.2 | g | O | chloride |
N01BB02 | lidocaine | null | null | null | null |
L04AB03 | afelimomab | null | null | null | null |
N02AC52 | methadone, combinations excl. psycholeptics | null | null | null | null |
A11AA04 | multivitamins and trace elements | null | null | null | null |
J06BB12 | encephalitis, tick borne immunoglobulin | null | null | null | null |
A12AA01 | calcium phosphate | 2 | g | O | null |
C01AC01 | g-strophanthin | 0.25 | mg | P | null |
D05 | ANTIPSORIATICS | null | null | null | null |
J05AR19 | emtricitabine, tenofovir alafenamide and rilpivirine | null | null | null | null |
S01XA13 | alteplase | null | null | null | null |
A10AE02 | insulin (beef) | 40 | U | P | null |
C09AA13 | moexipril | 15 | mg | O | null |
J07BM | Papillomavirus vaccines | null | null | null | null |
C07AA02 | oxprenolol | 0.16 | g | O | null |
C02AB | Methyldopa | null | null | null | null |
N05CD05 | triazolam | 0.2 | mg | SL | null |
G03DB06 | chlormadinone | null | null | null | null |
J05AE10 | darunavir | 1.2 | g | O | null |
A07EC02 | mesalazine | 1.5 | g | O | null |
L01EF | Cyclin-dependent kinase (CDK) inhibitors | null | null | null | null |
A11CC01 | ergocalciferol | null | null | null | null |
J01MA19 | garenoxacin | 0.4 | g | O | null |
A10BD03 | metformin and rosiglitazone | null | null | null | null |
C09CA04 | irbesartan | 0.15 | g | O | null |
N02BA04 | sodium salicylate | 3 | g | O | null |
P01AC04 | teclozan | null | null | null | null |
N03AX | Other antiepileptics | null | null | null | null |
G03AC09 | desogestrel | null | null | null | null |
G03XC03 | lasofoxifene | 0.5 | mg | O | null |
D08AF | Nitrofuran derivatives | null | null | null | null |
B06AX01 | crizanlizumab | null | null | null | null |
A03FA01 | metoclopramide | 30 | mg | R | null |
L01DB06 | idarubicin | null | null | null | null |
C01EB03 | indometacin | null | null | null | null |
N02BB54 | propyphenazone, combinations excl. psycholeptics | 3 | g | O | Refers to propyphenazone |
C03BA04 | chlortalidone | 25 | mg | O | null |
J01EB01 | sulfaisodimidine | 4 | g | O | null |
H01CC01 | ganirelix | 0.25 | mg | P | null |
V09FX01 | technetium (99mTc) pertechnetate | null | null | null | null |
J01CR | Combinations of penicillins, incl. beta-lactamase inhibitors | null | null | null | null |
J01CF02 | cloxacillin | 2 | g | P | null |
V01A | ALLERGENS | null | null | null | null |
C01DX07 | etafenone | 0.225 | g | O | null |
B01AE03 | argatroban | 0.2 | g | P | null |
N07XA | Gangliosides and ganglioside derivatives | null | null | null | null |
D07AA02 | hydrocortisone | null | null | null | null |
M03BX55 | thiocolchicoside, combinations | null | null | null | null |
N06AF06 | iproclozide | null | null | null | null |
H02AB05 | paramethasone | 4 | mg | P | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.